TOFACITINIB IN THE TREATMENT OF SEVERE AND REFRACTORY BEHCET'S DISEASE: A SINGLECENTRE EXPERIENCE IN CHINA

被引：0
|
作者：
Liu, J. [1 ]
Sun, L. [1 ]
Zhang, F. [1 ]
Zheng, W. [1 ]
机构：
[1] Peking Union Med Coll & Chinese Acad Med Sci, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DI, Key Lab Rheumatol & Clin Immunol, Peking Union Med Coll Hosp,Dept Rheumatol & Clin, Beijing, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.2802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0326
引用
收藏
页码：389 / 389
页数：1
相关论文
共 50 条
  • [31] Successful Treatment of Refractory Behcet's Disease with the TNF-α Blocker Infliximab
    Jalili, Ahmad
    Kinaciyan, Tamar
    Barisani, Talin
    Peck-Radosavljevic, Markus
    Stingl, Georg
    Geusau, Alexandra
    Woehrl, Stefan
    IRANIAN JOURNAL OF IMMUNOLOGY, 2009, 6 (01) : 55 - 58
  • [32] Interferon-alpha 2a treatment for refractory Behcet's disease
    Lai, Yung Jen
    Chan, Wei-Chun
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2018, 8 (03) : 168 - 172
  • [33] TOCILIZUMAB WAS EFFECTIVE IN REFRACTORY ARTERIAL INVOLVEMENT OF BEHCET'S DISEASE: A REAL-LIFE SINGLE- CENTER EXPERIENCE IN CHINA
    Zhong, H.
    Liu, T.
    Liu, Y.
    Zhang, X.
    Zhou, Y.
    Su, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1212 - 1213
  • [34] Behcet's Disease: Pakistani Experience
    Khan, Asadullah
    Haroon, Muhammad
    Bashir, Farhan
    Din, Zia ud
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2020, 36 (05) : 1005 - 1010
  • [35] Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease
    Lee, Scott David
    Singla, Anand
    Harper, Jason
    Barahimi, Mitra
    Jacobs, Jeffrey
    Kamp, Kendra J.
    Clark-Snustad, Kindra Dawn
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 4043 - 4048
  • [36] Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn’s Disease
    Scott David Lee
    Anand Singla
    Jason Harper
    Mitra Barahimi
    Jeffrey Jacobs
    Kendra J. Kamp
    Kindra Dawn Clark-Snustad
    Digestive Diseases and Sciences, 2022, 67 : 4043 - 4048
  • [37] Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet's disease
    Wechsler, B
    Bodaghi, B
    Huong, DLT
    Fardeau, C
    Amoura, Z
    Cassoux, N
    Piette, JC
    LeHoang, P
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2000, 8 (04) : 293 - 301
  • [38] Treatment of Behcet's disease
    Comarmond, C.
    Wechsler, B.
    Cacoub, P.
    Saadoun, D.
    REVUE DE MEDECINE INTERNE, 2014, 35 (02): : 126 - 138
  • [39] Treatment of Behcet's Disease
    Alpsoy, Erkan
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2007, 1 (01): : 1 - 7
  • [40] Allogeneic bone marrow transplantation (BMT) for refractory Behcet's disease with severe CNS involvement
    Marmont, A. M.
    Gualandi, F.
    Piaggio, G.
    Podesta, M.
    van Lint, M. Teresa
    Bacigalupo, A.
    Nobili, F.
    BONE MARROW TRANSPLANTATION, 2006, 37 (11) : 1061 - 1063
12345